-
Full assessment report available for first authorised COVID-19 vaccine
Full assessment report available for first authorised COVID-19 vaccine
-
Full assessment report available for first authorised COVID-19 vaccine
Full assessment report available for first authorised COVID-19 vaccine
EMA has published the assessment report for Comirnaty, the first COVID-19 vaccine to be authorised in the EU, together with the product information in all official EU languages.
-
Second public meeting on COVID-19 vaccines
Second public meeting on COVID-19 vaccines
-
Second public meeting on COVID-19 vaccines
Second public meeting on COVID-19 vaccines
Apply now to ask a question during our virtual meeting on Thursday 8 January. The event will be broadcast, with updates on the assessment, approval and roll-out of COVID-19 vaccines.
-
Management Board: Highlights of December 2020 meeting
Management Board: Highlights of December 2020 meeting
-
Management Board: Highlights of December 2020 meeting
Management Board: Highlights of December 2020 meeting
The Board focused in particular on the Agency’s activities in response to the COVID-19 pandemic. It also adopted EMA’s budget for 2021.
-
Development, evaluation and monitoring of COVID-19 vaccines
Development, evaluation and monitoring of COVID-19 vaccines
-
Development, evaluation and monitoring of COVID-19 vaccines
Development, evaluation and monitoring of COVID-19 vaccines
Read about how EMA is ensuring vaccines for COVID-19 meet the highest standards of quality, safety & efficacy while their development and approval is sped up due to the public health emergency.
